[PDF] Top 20 Botulinum toxin type-A therapy in cluster headache: an open study

... severe cluster attacks changed with intervals of spontaneous partial ...whereas cluster attacks were not ...accompanying headache was not before chronic CH started; this continuous headache ... See full document

... physical therapy and BTX-A or placebo injections reduced headache sever- ity, headache days per month and headache hours per ...of headache-free days and headache hours per day ... See full document

... chronic headache using 100 mice units (MU) of botulinum toxin performed by Farinelli et ...The study of Christidis et al. showed that other injection therapy is effective in ... See full document

... prospective open-label ...400 headache patients treated with BoNT-A, identifying 57 who received injections four or more ...retrospective open-label study measuring the effect of BoNT-A in 271 ... See full document

... of botulinum toxin in the treatment of TTH, yet, the results are ...and open-label studies have shown positive results, with sig- nificant improvement in different efficacy end points such as such as ... See full document

... Abstract Botulinum toxin type A (BoNT-A) has been recently sug- gested as prophylaxis therapy for the treatment of primary headache chronic ...sion-type headache and ... See full document

... conventional headache medications were based on drug acquisition costs, the average cost of the first treatment profile (those patients that did not modify their initial therapy) and the incremental cost ... See full document

... of botulinum toxin were ...in headache duration, pain intensity and pain sensitivity in 10 patients and found a lasting effect in long-term use over 15 months in 24 patients ...daily headache ... See full document

... Our study describes a typical case of New Daily Persistent Head- ache (NDPH), refractory to different therapies, that presented a satisfactory response to repeated cycles of botulinum toxin ... See full document

... pilot study demonstrates interest- ing results but further methodologically rigorous studies comprising large, prospective, randomised clinical trials are required to establish the potential role of BTX-A in the ... See full document

... otulinum toxin is a protein produced by Clostridium botulinum, a gram positive spore forming ...with botulinum toxin is very ...with botulinum toxin makes it a great concern for ... See full document

... [13]. Botulinum toxin (BTX) is a potent neurotoxin, used to treat different pathologies such as blepharospasm or spastic ...the toxin interferes with nerve impulses and causes flaccid paralysis of ... See full document

... In general, the injection procedure was well tolerated. The 2 participants who had hospital admissions for pro- longed seizures (1 intervention and 1 control) had a history of epileptic seizures before inclusion in the ... See full document

... potent toxin. Each vial of Botox (Botulinum Toxin Type A) contains 100 U of toxin, ...the toxin is drawn into the vial by the vacuum and not squirted into it and it is not ... See full document

... controlled study demonstrated that the therapeutic efficacy of BTX-A was significantly superior to that of placebo in pain intensity ...[56]. Open-label tri- als confirmed this trend ... See full document

... The introduction of increasing numbers of nonsurgical options for facial rejuvenation has revolutionized the aesthetic market. Cosmetic treatments were previously the sole province of the rich and famous but in the past ... See full document

... Botulism intoxication in cattle is a serious problem that needs to be addressed. Current vaccines offer protection but are based on lysed cells and inactivated toxin. These formulations are dangerous to produce ... See full document

... of botulinum toxin with 1–3 cc of ...comparative study for the treatment of blepharospasm showed no difference in efficacy or incidence of patient- reported complications (eg, bruising, redness, ... See full document

... our study had a double objective: first, to determine whether patients with CH develop sensory changes to mechanical stimuli in the symptomatic side compared to the asymptomatic side; second, to investigate ... See full document

... International Headache Society ...their headache condition as well as any adverse events or medications required for acute treat- ment of ...the study procedures had been carefully ... See full document